CARM: Carisma Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.32
Enterprise Value ($M) -7.56
Book Value ($M) -11.13
Book Value / Share -0.27
Price / Book -1.74
NCAV ($M) -19.05
NCAV / Share -0.46
Price / NCAV -1.01

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.71
Return on Equity (ROE) -2.40

Liquidity (mrq)
Quick Ratio 3.23
Current Ratio 3.23

Balance Sheet (mrq) ($M)
Current Assets 34.14
Assets 42.06
Liabilities 53.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-28 13D/A HealthCap VII, L.P. 8.20 0.00
03-13 13G AbbVie Biotechnology Ltd 6.80
2024-02-13 13G/A Vanguard Group Inc 3.89
2024-02-02 13G/A Longview Innovation Corp. 6.70 -6.29
2024-01-26 13D/A Trustees Of The University Of Pennsylvania 3.10 -42.64

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 12,748 170,937 7.46
2025-02-20 38,838 110,601 35.12
2025-02-19 51,595 129,604 39.81
2025-02-18 53,907 274,450 19.64

(click for more detail)

Similar Companies
BHST – BioHarvest Sciences Inc. BTMD – biote Corp.
CADL – Candel Therapeutics, Inc. CGTX – Cognition Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc.


Financial data and stock pages provided by
Fintel.io